CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Open-market buy CEO bought 10,730 shares at $2.33 ($25,001)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CFO acquired 3,931 shares (grant or award)
- 4 Grant or award Dir Govt Relations/Sectry acquired 6,879 shares (grant or award)
- 4 Grant or award Exec.Vice Chairman/CEO/Pres. acquired 14,741 shares (grant or award)
- 4 Other acquisition Director acquired 8,358 shares (other)
- 4 Other acquisition Director acquired 8,358 shares (other)
- 4 Grant or award CFO acquired 4,789 shares (grant or award)
- 4 Grant or award Dir Govt Relations/Sectry acquired 8,381 shares (grant or award)
- 4 Grant or award Exec.Vice Chairman/CEO/Pres. acquired 17,960 shares (grant or award)
- 4 Other acquisition Director acquired 9,503 shares (other)
- 4 Other acquisition Director acquired 9,503 shares (other)
- 4 Grant or award CFO acquired 5,208 shares (grant or award)
- 4 Grant or award Dir Govt Relations/Sectry acquired 9,115 shares (grant or award)
- 4 Grant or award Exec.Vice Chairman/CEO/Pres. acquired 19,531 shares (grant or award)
- 4 Other acquisition Director acquired 8,264 shares (other)
- 4 Other acquisition Director acquired 8,264 shares (other)
- 4 Grant or award CFO acquired 4,433 shares (grant or award)
Page 7 of 31 · 615 filings